Related Experiment Video
Updated: Feb 4, 2026

Optimized Minimally Invasive Transscleral Subretinal Injection Technique in Mouse
Published on: July 25, 2025
Efficacy and Safety of Micropulse® Transscleral Cyclophotocoagulation in Glaucoma
F G Sanchez1, F Lerner2, J Sampaolesi3
1Grippo Glaucoma Center, Buenos Aires, Argentina.
Objective:
To report the results using Micropulse® transscleral cyclophotocoagulation (Iridex) in the treatment of glaucoma.
Methods:
Retrospective study in adult patients with glaucoma with at least 6 months of follow-up, and only one session of Micropulse®. The same surgical technique was used in all cases. The only laser parameter that could vary was the total treatment duration (in seconds). The remaining parameters were fixed at 2 Watts of power and 0.5ms (31.3%) of active cycle.
Results:
A total of 22 eyes of 17 patients with glaucoma of various types and stages were included (mainly congenital and pseudoexfoliation). The mean follow-up time was 7.9 months. The total treatment duration varied from 100 to 180seconds. Definition of success: 5mmHg
Conclusions:
In a heterogeneous population of glaucoma (mostly congenital and pseudoexfoliation types), a low success rate (27.3%) was obtained in the medium-term with a single session of Micropulse®.
Related Concept Videos
Glaucoma: Overview
Survey Safety
Self-Efficacy
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Household Wiring And Electrical Safety

